Palisade Bio, Inc.
PALI
$1.87
-$0.05-2.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -166.12% | 17.75% | 31.76% | 36.77% | -12.55% |
| Total Depreciation and Amortization | -- | 0.00% | 0.00% | 0.00% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,540.99% | 3,381.82% | -80.34% | -34.00% | 9.36% |
| Change in Net Operating Assets | 185.02% | -412.57% | 613.39% | -203.57% | 3,268.18% |
| Cash from Operations | -32.05% | -13.41% | 48.07% | 26.64% | 13.29% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 10.26% | 10.71% | -- | 49.37% | -54.46% |
| Issuance of Common Stock | 2,873.43% | -- | -99.90% | -- | 26,005.88% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -308.33% | -554.41% | 100.00% | 44.55% | -140.00% |
| Cash from Financing | 3,055.48% | 1,968.33% | -99.89% | -112.75% | 3,205.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7,097.47% | 94.27% | -2,454.55% | -124.13% | 161.84% |